The COVID-19 delta variant is spreading rapidly around the world, just as many people were beginning to feel hopeful that the pandemic was coming to an end. Despite the spread of this new, more contagious strain, there’s still room for cautious optimism that we can halt the spread.
A new study finds that remdesivir, the first new medicine approved for treatment of COVID-19, is not associated with improved survival, but is associated with longer hospital stays for patients.
In mid-May, the Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to include adolescents ages 12 through 15.
UI Health Care workers were among the first Iowans to get the COVID-19 vaccine. As a part of receiving the vaccine, many employees were sent a survey about their symptoms. Learn about side effects from their experience here.
You should beware of scammers looking to take advantage of you during the COVID-19 pandemic. Many emerging scams can compromise your personal information.
Watch Chief Pharmacy Officer Mike Brownlee, PharmD, MS, FASHP, discuss the University of Iowa Hospitals & Clinics vaccination program and answer questions about navigating this process.
University of Iowa Health Care today took its next big step in continued preparations to keep our community safe from COVID-19. This afternoon, UI Health Care is on track to administer 1,000 pre-scheduled doses at one location in a single day to Johnson County residents age 65 or older who are newly eligible under Phase 1b of the state's vaccination guidance.
Wonder what it’s like to get a COVID-19 vaccine? University of Iowa Health Care employees are sharing their experiences through video diaries. See what they have to say about receiving the second dose.
With approval by the Food and Drug Administration for the first emergency use of a COVID-19 vaccine, we have the potential to reach a turning point in the fight to end the pandemic. Read more from UI Hospitals & Clinics CEO Suresh Gunasekaran, MBA.
